U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07034690) titled 'Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia' on June 16.
Brief Summary: This study is an open label, randomized, prospective, type I hybrid effectiveness- implementation, pragmatic clinical trial to evaluate the impact of a targeted lipid optimization program on LDL-C control in participants with dyslipidemia who are at high risk or very high risk of cardiovascular events.
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Atherosclerotic Cardiovascular Disease
Intervention:
OTHER: Educational Material
Health Education Interven...